Pacific Biosciences of California Inc
XBER:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
XBER:P09
|
US |
|
Smith Micro Software Inc
NASDAQ:SMSI
|
US |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
A
|
American Eagle Outfitters Inc
XMUN:AFG
|
US |
|
E
|
Extreme Networks Inc
XMUN:EXM
|
US |
|
Bureau Veritas SA
PAR:BVI
|
FR |
|
Helvetia Holding AG
OTC:HLVTY
|
CH |
|
Canada Goose Holdings Inc
LSE:0UNA
|
CA |
|
T
|
Textron Inc
DUS:TXT
|
US |
|
B
|
Bank Mandiri (Persero) Tbk PT
XMUN:PQ9
|
ID |
|
JD.Com Inc
HKEX:89618
|
CN |
|
Ke Holdings Inc
F:KE8
|
CN |
|
NRJ Group SA
F:NR8
|
FR |
|
CVR Energy Inc
LSE:0HRR
|
US |
|
B
|
Bank Mandiri (Persero) Tbk PT
SWB:PQ9
|
ID |
Wall St Price Targets
P09 Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for P09 is 1.9123 EUR with a low forecast of 1.1554 EUR and a high forecast of 2.4024 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P09's stock price target?
Price Target
1.9123
EUR
According to Wall Street analysts, the average 1-year price target for P09 is 1.9123 EUR with a low forecast of 1.1554 EUR and a high forecast of 2.4024 EUR.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 28%.
